17th Annual Medical Device Coverage & Reimbursement Conference

September 15-16, 2021 | Chicago, IL
Access Agenda

Pricing:
$2050 per attendee for in-person, Virtual attendance and pricing is available.

Target Audience:
Reimbursement
Market Access
Health Economics
Marketing

 
Industries Represented:
Medical Device

Aaron Vandyke

 

 

 

 

Contact:

Aaron Van Dyke
Operations Director, Life Science
Q1 Productions
+1 (312) 955-0825
avandyke@q1productions.com

Optimize payer communication & secure reimbursement by demonstrating medical necessity & exploring risk arrangements in transitioning to value-based care

Combining stakeholder perspectives, including payers, contracting executives, value analysis committees and innovative medical device manufacturers, this event gives insight into expanding market access and securing coverage and reimbursement for medical technologies. Innovative case studies highlight success stories and provide analysis from critical payer stakeholders in the form of commercial and Medicare Administrative Contractor medical directors, value analysis committees and stakeholder groups. The event delivers a first-in-class educational and networking platform for medical device reimbursement executives.

FAQ

Foster a sense of collaboration and safely connect with peers and expert presenters at this intimately-sized program. Customize your experience and address your unique concerns during dynamic Q&A after each session. Our commitment to industry perspectives keeps the program focused on what matters and dynamic session types allow you to stay engaged.  

 

Media Partner:

BioMedWire Logo

BioMedWire (BMW), a technology-driven communications platform, is a digital hub committed to connecting the public to emerging market opportunities in life sciences and beyond. We cover companies and events in the fields of biotechnology, pharmaceuticals, life systems technologies, environmental, nutraceuticals, cosmeceuticals, medical, biomedical devices, and more. We also delve into the companies and institutions that are devoted to research and development of the next cancer therapeutic, critical device or lifesaving vaccine.